The 'good', the 'bad', and the 'ugly' rectal cancers

Acta Oncologica

Volumn 47, Issue 1, 2008, Pages 5-8

  Blomqvist, Lennart ^a   Glimelius, Bengt ^a,b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; FLUOROURACIL; OXALIPLATIN;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIGITAL RECTAL EXAMINATION; EDITORIAL; HISTOPATHOLOGY; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RECTUM RESECTION;

CHEMOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; NEOPLASM STAGING; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 37549067807     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701802585     Document Type: Editorial

References (31)

1. Talbäck M, Stenbeck M, Rosén M, Glimelius B. Cancer survival in Sweden. Acta Oncol 2003;42:637-59.
2. Kapiteijn E, Marijnen CA, Colenbrander AC, Klein Kranenbarg E, Steup WH, van Krieken JH, et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the west Netherlands. Eur J Surg Oncol 1998;24:528-35.
3. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007;14:447-54.
4. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-6.
5. Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999;86:379-84.
6. Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845-53.
7. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002;89:1142-9.
8. Colorectal Cancer Collaborative Group. Adjuvant therapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials. Lancet 2001;358:1291-304.
9. Glimelius B, Grönberg H, Järhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42:476-92.
10. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007;94:113-8.
11. Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer-a systematic overview. Acta Oncol 2007;46:504-16.
12. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 2004;232:773-83.
13. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al . Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668-74.
14. Blomqvist L, Holm T, Nyren S, Svanstrom R, Ulvskog Y, Iselius L. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol 2002;57:211-8.
15. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007;188:442-51.
16. Brown G, Daniels IR. Preoperative staging of rectal cancer: The MERCURY research project. Recent Results Cancer Res 2005;165:58-74.
17. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007;243:132-9.
18. Smith N, Brown G. Preoperative staging in rectal cancer. Acta Oncol 2008;47:20-31.
19. Glimelius B. Rectal cancer irradiation. Long course, short course or something else? Acta Oncol 2006;45:1013-7.
20. Smith NJ , Barbachano Y , Norman AR , Swift RI , Abulafi AM . Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007;(in press).
21. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-23.
22. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006;24:4620-5.
23. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy vs preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-23.
24. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, et al, for the NCRI colorectal cancer study group and CR07. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006;Proc ASCO;24:Abstr 3511.
25. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
26. Braendengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, et al.A randomized phase III study (LARCS) comparing preoperative radiotherapy alone versus chemoradiotherapy in non-resectable rectal cancer. Eur J Cancer 2005; ECCO 13. Abstr 612.
27. Frykholm GJ, Pahlman L, Glimelius B. Combined chemo-and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001;50:427-34.
28. Pfeiffer P. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial. Acta Oncol 2005;44:224-9.
29. Glimelius B. Chemoradiotherapy for rectal cancer-is there an optimal combination? Ann Oncol 2001;12:1039-45.
30. Courdi A. Fractionation sensitivity and equivalent doses. Commenting the Editorial by Glimelius. Acta Oncol 2007;46:395-6; author reply 396.
31. Suwinski R, Wzietek I, Tarnawski R, Namysl-Kaletka A, Kryj M, Chmielarz A, et al. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:793-9.